Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02499952
Title Pembrolizumab in Subjects With Incurable Platinum-Refractory Germ Cell Tumors
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Nasser Hanna, M.D.
Indications

germ cell cancer

Therapies

Pembrolizumab

Age Groups: adult
Covered Countries USA


No variant requirements are available.